What is he best known for?
The fields of study he is best known for:
- Cancer
- Internal medicine
- Surgery
His primary areas of investigation include Surgery, Radiation therapy, Internal medicine, Medulloblastoma and Chemotherapy.
His Surgery research includes themes of Pediatrics and Glioma.
His Glioma research incorporates themes from Radiology, Neurofibromatosis and Neuroscience.
Roger J. Packer has researched Radiation therapy in several fields, including Lomustine, Cancer and Regimen.
His studies in Internal medicine integrate themes in fields like Gastroenterology, Oncology and Pathology.
His research in Medulloblastoma intersects with topics in Clinical trial, Quality of life, Primitive neuroectodermal tumor, Proportional hazards model and Disease.
His most cited work include:
- Central nervous system atypical teratoid/rhabdoid tumors of infancy and childhood: definition of an entity (614 citations)
- Phase III study of craniospinal radiation therapy followed by adjuvant chemotherapy for newly diagnosed average-risk medulloblastoma. (603 citations)
- Metastasis Stage, Adjuvant Treatment, and Residual Tumor Are Prognostic Factors for Medulloblastoma in Children: Conclusions From the Children's Cancer Group 921 Randomized Phase III Study (568 citations)
What are the main themes of his work throughout his whole career to date?
His primary scientific interests are in Internal medicine, Surgery, Oncology, Pathology and Radiation therapy.
The study incorporates disciplines such as Medulloblastoma and Glioma in addition to Internal medicine.
He has researched Medulloblastoma in several fields, including Disease and Primitive neuroectodermal tumor.
His Surgery study combines topics from a wide range of disciplines, such as Toxicity, Pediatrics and Neurofibromatosis.
His Pathology research incorporates themes from Astrocytoma and Central nervous system.
As part of one scientific family, Roger J. Packer deals mainly with the area of Radiation therapy, narrowing it down to issues related to the Chemotherapy, and often Regimen.
He most often published in these fields:
- Internal medicine (30.36%)
- Surgery (28.33%)
- Oncology (25.20%)
What were the highlights of his more recent work (between 2017-2021)?
- Internal medicine (30.36%)
- Oncology (25.20%)
- Clinical trial (11.42%)
In recent papers he was focusing on the following fields of study:
Roger J. Packer spends much of his time researching Internal medicine, Oncology, Clinical trial, Glioma and Neurofibromatosis.
His work in the fields of Pediatric Neuro-Oncology overlaps with other areas such as Isotretinoin.
His biological study spans a wide range of topics, including Medulloblastoma, BRAF V600E, Chemotherapy and Low-Grade Glioma.
His Chemotherapy study frequently links to adjacent areas such as Radiation therapy.
Roger J. Packer has included themes like Cancer, Precision medicine, Magnetic resonance imaging and Progression-free survival in his Glioma study.
The Neurofibromatosis study combines topics in areas such as Cabozantinib, Cognition, Everolimus, Prospective cohort study and Pediatrics.
Between 2017 and 2021, his most popular works were:
- Selumetinib in paediatric patients with BRAF-aberrant or neurofibromatosis type 1-associated recurrent, refractory, or progressive low-grade glioma: a multicentre, phase 2 trial. (106 citations)
- Clinical, Radiologic, Pathologic, and Molecular Characteristics of Long-Term Survivors of Diffuse Intrinsic Pontine Glioma (DIPG): A Collaborative Report From the International and European Society for Pediatric Oncology DIPG Registries. (92 citations)
- Pediatric low-grade gliomas: next biologically driven steps. (55 citations)
In his most recent research, the most cited papers focused on:
- Cancer
- Internal medicine
- Disease
His main research concerns Internal medicine, Clinical trial, Glioma, Oncology and Neurofibromatosis.
Internal medicine and In patient are two areas of study in which Roger J. Packer engages in interdisciplinary work.
His studies deal with areas such as Cancer, Pediatric Neuro-Oncology, MEDLINE, Disease and Response assessment as well as Clinical trial.
His study focuses on the intersection of Response assessment and fields such as Confounding with connections in the field of Medulloblastoma.
His studies in Glioma integrate themes in fields like Targeted therapy, Magnetic resonance imaging, Biopsy and Consensus conference.
His work carried out in the field of Oncology brings together such families of science as Exome sequencing, Precision medicine, MEK inhibitor and BRAF V600E.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
